As of early 2026, multiple Phase 3 trials have reported positive topline results, regulatory submissions have been filed, and the FDA is reviewing orforglipron for an obesity indication with a target action date of April 10, 2026
GLP-1 agonists have been used to treat type 2 diabetes for about two decades
These foods are especially effective at supporting digestive health during GLP-1 therapy: Non-starchy vegetables (spinach, kale, broccoli, zucchini) provide insoluble fiber and water content
At A New You Aesthetic Spa in Lapeer and Oxford, MI we know that part of your overall wellness is also feeling good about your weight
As with any medication, its important to discuss the potential benefits and risks with your healthcare provider to determine if GLP-1 agonists are a suitable option for you